ClinicalTrials.gg
Sign In

Drug

Rocbrutinib clinical trials

Also written LP-168 and NWP-775.

studies test it
16
open now
11
in phase 3
2
first study started
2021

Keep track of what changes. Save the rocbrutinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Rocbrutinib
7
LP-168 tablet
3

Development codes

LP-168
6
NWP-775
3
HS-10561
1

Combined with it in one product

Lacutoclax+Rocbrutinib
1

Studies by the year they started

16 studies that test it; most in 2026 (6)

Studies that test rocbrutinib, by start year
YearStudies
20212
20221
20233
20241
20253
20266

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
6
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Lymphoma, Mantle-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
2
Multiple Sclerosis
1
Chronic Urticaria
1
Lymphoma, B-Cell
1
Multiple Sclerosis, Relapsing-Remitting
1
Waldenstrom Macroglobulinemia
1
Lymphoma, Large B-Cell, Diffuse
1

Who runs them

Industry 15 · Other 1

Guangzhou Lupeng Pharmaceutical Company LTD. (12) · Newave Pharmaceutical Inc (2) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Zulfa Omer (1)

Often tested with

Tested in the same studies.

R-GemOx Regimen (1) · Lacutoclax (1) · Itraconazole (1) · Obinutuzumab (1)

Studies

Open first, then newest update. How each study uses rocbrutinib is read from its arms, and is right about nine times in ten.

Testing it · 16

Codes

What other systems call rocbrutinib · ClinicalTrials.gg INT017056

  • UNII (FDA) KD68L3GRW2ROCBRUTINIBConfirmed FDA, Wikidata
  • Wikidata Q140641595rocbrutinibConfirmed FDA, Wikidata
  • NCI Thesaurus C203033RocbrutinibOne source FDA
  • DrugBank DB19445One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.